Correlating programmed death ligand 1 (PD-L1) expression, mismatch repair deficiency, and outcomes across tumor types: implications for immunotherapy.

Oncotarget · 2017 · PMC5652789 · PMID 29100397

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Admittedly, only a small fraction (4.5%, 18/394 evaluable) of patients had dMMR tumors and the numerical increase in PD-L1+ samples did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.